Purpose To assess how the molecular biomarker status of a breast cancer, including human
epidermal growth factor receptor 2 (HER2), hormone receptors, and the proliferation marker …

Neoadjuvant chemotherapy (NAC) or primary systemic therapy given before surgery is now
widely used as an alternative to the traditional approach of postoperative adjuvant …

OBJECTIVE. Our study investigated the usefulness of contrast-enhanced MR imaging for
accurately measuring the size of residual tumor after patients have undergone neoadjuvant …

OBJECTIVE. This study was undertaken to evaluate the ability of MRI to accurately show
residual primary breast malignancy in women treated with neoadjuvant chemotherapy …

BACKGROUND. This study investigated the role of magnetic resonance imaging (MRI) in
evaluation of pathologically complete response and residual tumors in patients who were …

Purpose To compare magnetic resonance (MR) imaging findings and clinical assessment
for prediction of pathologic response to neoadjuvant chemotherapy (NACT) in patients with …

Background This study aimed to evaluate the influence of hormone receptor (HR) and Ki-67
proliferation markers in predicting the accuracy of magnetic resonance imaging (MRI) for …

Background Prior studies of the ability of magnetic resonance imaging (MRI) to predict
pathologic response to neoadjuvant chemotherapy have shown conflicting results that vary …

Magnetic resonance imaging (MRI) is highly sensitive in identifying residual breast cancer
following neoadjuvant chemotherapy (NAC), and consequently is a commonly used imaging …

BACKGROUND: Increased pathologic complete response (pCR) rates observed with
neoadjuvant chemotherapy (NCT) for some subsets of patients with invasive breast cancer …